Schedule 13G ownership disclosure

Aegerion Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 00767E102

Event date: 2016-11-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000891092-16-019320
Form type
SC 13G/A
Filer
Aegerion Pharmaceuticals, Inc.
CIK
CIK 1338042
Filed
Dec 05, 2016
Reporting period
Nov 29, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub